AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Citadel Group

Major Shareholding Notification Dec 2, 2025

10454_rns_2025-12-02_6abeaed6-46b8-4521-919d-a02e15193b73.html

Major Shareholding Notification

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

RNS Number : 9027J

Citadel Group

02 December 2025

Ap27

FORM 8.3

IRISH TAKEOVER PANEL

OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER

RULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1.             KEY INFORMATION

(a)   Full name of discloser Citadel Group
(b)   Owner or controller of interests and short positions disclosed, if different from 1(a)

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.
N/A
(c)   Name of offeror/offeree in relation to whose relevant securities this form relates

Use a separate form for each offeror/offeree
AVADEL PHARMACEUTICALS PLC
(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree (Note 1) N/A
(e)   Date position held/dealing undertaken

For an opening position disclosure, state the latest practicable date prior to the disclosure
1 December 2025
(f)    In addition to the company in 1(c) above, is the discloser also making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"
N/A

2.             INTERESTS AND SHORT POSITIONS

If there are interests and short positions to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2 for each additional class of relevant security.

Ap28

Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

(Note 2)

Class of relevant security

(Note 3)
Common Stock ISIN IE00BDGMC594

$0.01 ordinary shares
Interests Short positions
Number % Number %
(1)   Relevant securities owned and/or controlled 972,622 0.99 317,885 0.32
(2)   Cash-settled derivatives 0 0.00 0 0.00
(3)   Stock-settled derivatives (including options) and agreements to purchase/ sell 162,400 0.16 783,000 0.80
Total 1,135,022 1.16 1,100,885 1.12

All interests and all short positions should be disclosed.

Details of options including rights to subscribe for new securities and any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8.

3.             DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE (Note 4)

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a)           Purchases and sales

Class of relevant

security
Purchase/sale Number of

securities
Price per unit

(Note 5)
Common Buy Transaction 775 21.3650 USD
Common Buy Transaction 11 21.3700 USD
Common Buy Transaction 16 21.3719 USD
Common Buy Transaction 156 21.3732 USD
Common Buy Transaction 6 21.3767 USD
Common Buy Transaction 13 21.3831 USD
Common Buy Transaction 1,590 21.3907 USD
Common Buy Transaction 609 21.3923 USD
Common Buy Transaction 22 21.3959 USD
Common Buy Transaction 207 21.3971 USD
Common Buy Transaction 7 21.4000 USD
Common Buy Transaction 57 21.4037 USD
Common Buy Transaction 1,191 21.4039 USD
Common Buy Transaction 5 21.4040 USD
Common Buy Transaction 71 21.4072 USD
Common Buy Transaction 1,096 21.4079 USD
Common Buy Transaction 475 21.4100 USD
Common Buy Transaction 300 21.4101 USD
Common Buy Transaction 68 21.4115 USD
Common Buy Transaction 500 21.4120 USD
Common Buy Transaction 73 21.4127 USD
Common Buy Transaction 141 21.4131 USD
Common Buy Transaction 389 21.4150 USD
Common Buy Transaction 246 21.4151 USD
Common Buy Transaction 61 21.4151 USD
Common Buy Transaction 118 21.4152 USD
Common Buy Transaction 1,548 21.4152 USD
Common Buy Transaction 279 21.4156 USD
Common Buy Transaction 1,665 21.4165 USD
Common Buy Transaction 31 21.4168 USD
Common Buy Transaction 1,979 21.4175 USD
Common Buy Transaction 200 21.4175 USD
Common Buy Transaction 2,646 21.4183 USD
Common Buy Transaction 285 21.4185 USD
Common Buy Transaction 4,211 21.4186 USD
Common Buy Transaction 167 21.4187 USD
Common Buy Transaction 1,346 21.4189 USD
Common Buy Transaction 3,159 21.4197 USD
Common Buy Transaction 806 21.4200 USD
Common Buy Transaction 10,177 21.4200 USD
Common Buy Transaction 1,600 21.4225 USD
Common Buy Transaction 80 21.4250 USD
Common Buy Transaction 2,866 21.4279 USD
Common Buy Transaction 645 21.4334 USD
Common Buy Transaction 1,142 21.4335 USD
Common Buy Transaction 503 21.4365 USD
Common Buy Transaction 250 21.4380 USD
Common Buy Transaction 593 21.4390 USD
Common Buy Transaction 1,245 21.4400 USD
Common Buy Transaction 235 21.4404 USD
Common Buy Transaction 50 21.4416 USD
Common Buy Transaction 18 21.4433 USD
Common Buy Transaction 630 21.4435 USD
Common Buy Transaction 137 21.4436 USD
Common Buy Transaction 2,029 21.4437 USD
Common Buy Transaction 162 21.4438 USD
Common Buy Transaction 5 21.4440 USD
Common Buy Transaction 46 21.4450 USD
Common Buy Transaction 2,966 21.4452 USD
Common Buy Transaction 22 21.4455 USD
Common Buy Transaction 3,220 21.4476 USD
Common Buy Transaction 780 21.4491 USD
Common Buy Transaction 566 21.4500 USD
Common Buy Transaction 600 21.4501 USD
Common Buy Transaction 187 21.4501 USD
Common Buy Transaction 93 21.4501 USD
Common Buy Transaction 88 21.4501 USD
Common Buy Transaction 4,609 21.4527 USD
Common Buy Transaction 303 21.4533 USD
Common Buy Transaction 260 21.4535 USD
Common Buy Transaction 32 21.4550 USD
Common Buy Transaction 300 21.4551 USD
Common Buy Transaction 68 21.4551 USD
Common Buy Transaction 100 21.4600 USD
Common Buy Transaction 435 21.4628 USD
Common Buy Transaction 371 21.4646 USD
Common Buy Transaction 1,730 21.4647 USD
Common Buy Transaction 477 21.4666 USD
Common Buy Transaction 3,897 21.4693 USD
Common Buy Transaction 294 21.4700 USD
Common Buy Transaction 580 21.4714 USD
Common Buy Transaction 1,047 21.4714 USD
Common Buy Transaction 200 21.4750 USD
Common Buy Transaction 136 21.4882 USD
Common Buy Transaction 150 21.4900 USD
Common Buy Transaction 551 21.5000 USD
Common Buy Transaction 739 21.5500 USD
Common Buy Transaction 30 21.5600 USD
Common Sell Transaction 258 21.3800 USD
Common Sell Transaction 250 21.3900 USD
Common Sell Transaction 3,012 21.3950 USD
Common Sell Transaction 49 21.3951 USD
Common Sell Transaction 131 21.3963 USD
Common Sell Transaction 1,320 21.3995 USD
Common Sell Transaction 84 21.4000 USD
Common Sell Transaction 146 21.4026 USD
Common Sell Transaction 32 21.4031 USD
Common Sell Transaction 163 21.4057 USD
Common Sell Transaction 44 21.4100 USD
Common Sell Transaction 517 21.4117 USD
Common Sell Transaction 1,013 21.4138 USD
Common Sell Transaction 7,264 21.4150 USD
Common Sell Transaction 1,495 21.4162 USD
Common Sell Transaction 9 21.4167 USD
Common Sell Transaction 390 21.4169 USD
Common Sell Transaction 4,635 21.4170 USD
Common Sell Transaction 110 21.4173 USD
Common Sell Transaction 450 21.4180 USD
Common Sell Transaction 604 21.4181 USD
Common Sell Transaction 1,442 21.4185 USD
Common Sell Transaction 7,620 21.4200 USD
Common Sell Transaction 10,558 21.4210 USD
Common Sell Transaction 384 21.4213 USD
Common Sell Transaction 31 21.4216 USD
Common Sell Transaction 4,312 21.4230 USD
Common Sell Transaction 506 21.4233 USD
Common Sell Transaction 227 21.4236 USD
Common Sell Transaction 820 21.4245 USD
Common Sell Transaction 589 21.4255 USD
Common Sell Transaction 505 21.4260 USD
Common Sell Transaction 11 21.4264 USD
Common Sell Transaction 1,117 21.4300 USD
Common Sell Transaction 576 21.4312 USD
Common Sell Transaction 2,716 21.4335 USD
Common Sell Transaction 2 21.4350 USD
Common Sell Transaction 800 21.4375 USD
Common Sell Transaction 153 21.4393 USD
Common Sell Transaction 601 21.4400 USD
Common Sell Transaction 130 21.4431 USD
Common Sell Transaction 360 21.4441 USD
Common Sell Transaction 404 21.4450 USD
Common Sell Transaction 7 21.4471 USD
Common Sell Transaction 644 21.4487 USD
Common Sell Transaction 3,424 21.4500 USD
Common Sell Transaction 132 21.4512 USD
Common Sell Transaction 300 21.4517 USD
Common Sell Transaction 573 21.4523 USD
Common Sell Transaction 30 21.4550 USD
Common Sell Transaction 1 21.4600 USD
Common Sell Transaction 1,603 21.4601 USD
Common Sell Transaction 18 21.4650 USD
Common Sell Transaction 101 21.4700 USD
Common Sell Transaction 66 21.5300 USD
Common Sell Transaction 30 21.5600 USD

Ap29

(b)           Cash-settled derivative transactions

Class of

relevant

security
Product

description

e.g. CFD
Nature of dealing

e.g. opening/ closing a long/ short position, increasing/ reducing a long/ short position
Number of

reference

securities

(Note 6)
Price

per unit

(Note 5)

(c)           Stock-settled derivative transactions (including options)

(i)            Writing, selling, purchasing or varying

Class of

relevant

security
Product

description e.g. call

option
Writing, purchasing, selling, varying

etc.
Number

of

securities

to which

option

relates

(Note 6)
Exercise

price per

unit
Type

e.g.

American,

European

etc.
Expiry

date
Option

money

paid/

received per unit
Common Call Option Buy Transaction 200 10.0000 USD American 2026-01-16 11.5000 USD
Common Call Option Sell Transaction 500 22.5000 USD American 2025-12-19 0.0900 USD

(ii)           Exercise

Class of

relevant

security
Product

description

e.g. call

option
Exercising/

exercised

against
Number of

securities
Exercise

price per

unit

(Note 5)

(d)           Other dealings (including transactions in respect of new securities) (Note 3)

Class of

relevant

security
Nature of dealing

e.g. subscription,

conversion, exercise
Details Price per unit (if

applicable)

(Note 5)

Ap30

4.             OTHER INFORMATION

(a)           Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer.

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"
None

(b)           Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
None

(c)           Attachments

Is a Supplemental Form 8 attached? YES
Date of disclosure 2 December 2025
Contact name Paula Santos
Telephone number 020 7645 9700

Public disclosures under Rule 8.3 of the Rules must be made to a Regulatory Information Service.

Ap32

SUPPLEMENTAL FORM 8

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.1, RULE 8.3, RULE 38.5(b) AND

RULE 38.6 OF THE IRISH TAKEOVER PANEL ACT, 1997,

TAKEOVER RULES, 2022

DETAILS OF OPEN STOCK-SETTLED DERIVATIVE (INCLUDING

OPTION) POSITIONS, AGREEMENTS TO PURCHASE OR SELL AND

RIGHTS TO SUBSCRIBE FOR NEW SECURITIES

1.             KEY INFORMATION

Full name of person making

disclosure:
Citadel Group
Name of offeror/offeree in relation

to whose relevant securities the

disclosure relates:
AVADEL PHARMACEUTICALS PLC

2.             STOCK-SETTLED DERIVATIVES (INCLUDING OPTIONS)

Class of

relevant

security
Product

description

e.g. call

option
Written or

purchased
Number of

securities to

which option

or derivative

relates
Exercise

price

per unit
Type

e.g.

American,

European

etc.
Expiry

date
Common Call Option Purchased 900 7.5 USD American 19/12/2025
Common Call Option Purchased 24,200 22.5 USD American 20/03/2026
Common Put Option Purchased -3,100 12.5 USD American 20/03/2026
Common Put Option Purchased -100 20.0 USD American 18/06/2026
Common Call Option Purchased 0 25.0 USD American 20/03/2026
Common Put Option Purchased -60,700 15.0 USD American 16/01/2026
Common Put Option Purchased -2,900 7.5 USD American 19/12/2025
Common Call Option Purchased 5,600 12.5 USD American 15/01/2027
Common Put Option Purchased -44,400 10.0 USD American 16/01/2026
Common Put Option Purchased -3,800 15.0 USD American 20/03/2026
Common Put Option Purchased 0 10.0 USD American 20/03/2026
Common Call Option Purchased 5,100 15.0 USD American 15/01/2027
Common Call Option Purchased 3,000 25.0 USD American 15/01/2027
Common Call Option Purchased 0 5.0 USD American 16/01/2026
Common Call Option Purchased 4,200 17.5 USD American 16/01/2026
Common Put Option Purchased -4,700 15.0 USD American 19/12/2025
Common Call Option Purchased 100 22.5 USD American 16/01/2026
Common Put Option Purchased -1,000 17.5 USD American 18/06/2026
Common Put Option Purchased 0 12.5 USD American 15/01/2027
Common Put Option Purchased -200 17.5 USD American 20/03/2026
Common Put Option Purchased -100 15.0 USD American 15/01/2027
Common Put Option Purchased -900 25.0 USD American 20/03/2026
Common Call Option Purchased 5,800 22.5 USD American 15/01/2027
Common Put Option Purchased -100 7.5 USD American 20/03/2026
Common Call Option Purchased 2,200 20.0 USD American 18/06/2026
Common Call Option Sold -183,000 10.0 USD American 16/01/2026
Common Call Option Sold -4,900 22.5 USD American 19/12/2025
Common Call Option Sold -65,900 12.5 USD American 16/01/2026
Common Call Option Sold -4,800 17.5 USD American 15/01/2027
Common Put Option Sold 24,900 7.5 USD American 16/01/2026
Common Call Option Sold -13,500 10.0 USD American 15/01/2027
Common Call Option Sold -100 30.0 USD American 19/12/2025
Common Call Option Sold -30,000 15.0 USD American 20/03/2026
Common Call Option Sold -38,000 15.0 USD American 19/12/2025
Common Call Option Sold -6,200 12.5 USD American 19/12/2025
Common Call Option Sold -6,800 25.0 USD American 19/12/2025
Common Call Option Sold -5,400 20.0 USD American 20/03/2026
Common Call Option Sold -1,700 25.0 USD American 16/01/2026
Common Put Option Sold 59,000 5.0 USD American 16/01/2026
Common Put Option Sold 1,600 12.5 USD American 19/12/2025
Common Call Option Sold -9,600 7.5 USD American 16/01/2026
Common Call Option Sold -31,800 17.5 USD American 19/12/2025
Common Call Option Sold -46,200 20.0 USD American 16/01/2026
Common Put Option Sold 2,000 17.5 USD American 19/12/2025
Common Put Option Sold 8,200 10.0 USD American 19/12/2025
Common Call Option Sold -700 20.0 USD American 19/12/2025
Common Put Option Sold 5,300 20.0 USD American 19/12/2025
Common Call Option Sold -10,200 7.5 USD American 15/01/2027
Common Call Option Sold -2,100 12.5 USD American 20/03/2026
Common Call Option Sold -10,000 17.5 USD American 20/03/2026
Common Call Option Sold -148,000 15.0 USD American 16/01/2026
Common Call Option Sold -100 35.0 USD American 16/01/2026
Common Put Option Sold 5,500 12.5 USD American 16/01/2026
Common Call Option Sold -34,200 5.0 USD American 15/01/2027
Common Call Option Sold -2,600 30.0 USD American 16/01/2026
Common Put Option Sold 4,400 17.5 USD American 16/01/2026
Common Call Option Sold -100 20.0 USD American 15/01/2027
Common Put Option Sold 400 20.0 USD American 20/03/2026
Common Call Option Sold -5,100 10.0 USD American 19/12/2025

3.             AGREEMENTS TO PURCHASE OR SELL

Full details should be given so that the nature of the interest or position can be fully understood:

Ap33

4.             RIGHTS TO SUBSCRIBE FOR NEW SECURITIES (INCLUDING DIRECTORS' AND OTHER EMPLOYEE OPTIONS)

Class of relevant security in relation to which subscription right exists:
Details, including nature of the rights concerned and relevant percentages:

It is not necessary to provide details on a Supplemental Form with regard to cash-settled derivatives.

The currency of all prices and other monetary amounts should be stated.

For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.

References in these notes to "the Rules" are to the Irish Takeover Panel Act, 1997, Takeover Rules, 2022.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

ITPTTBBTMTTMBMA

Talk to a Data Expert

Have a question? We'll get back to you promptly.